Harris & Harris Group Notes Unilever's Purchase of Algae-Produced Oil From Solazyme

Harris & Harris Group Notes Unilever's Purchase of Algae-Produced Oil From

NEW YORK, Sept. 25, 2013 (GLOBE NEWSWIRE) -- Harris & Harris Group, Inc.
(Nasdaq:TINY), an early-stage, active investor in transformative companies,
notes an article in The New York Times discussing the purchase by Unilever,
the consumer products giant, of large amounts of oil from Solazyme, Inc., a
start-up company that bioengineers algae to produce oils, proteins and complex

Unilever said it would use the oil for its personal care products, which
include Dove and Brylcreem. The agreement, under which Unilever plans to buy
roughly three million gallons of the algae-produced oil over 12 to 18 months
starting early next year, is part of its aim to double the size of its
business while reducing its overall environmental footprint. For Solazyme,
the agreement represents an important step as it ramps up to commercial-scale
production. Originally conceived as a fuel business, Solazyme has focused on
making oils for products with higher profit margins like personal care, food
and petrochemicals. The Unilever oil, developed in a five-year partnership
with Solazyme, will be made at a plant it built in Brazil with Bunge, a
leading agribusiness and food company. When fully operational, the plant
could produce roughly 30 million gallons of oil a year. The article in The New
York Times can be accessed at

Harris & Harris Group is an investor in publicly traded Solazyme, Inc., and
was its first institutional investor in 2004.

Detailed information about Harris & Harris Group and its holdings can be found
on its website at www.HHVC.com and on Facebook at

This press release may contain statements of a forward-looking nature relating
to future events. These forward-looking statements are subject to the inherent
uncertainties in predicting future results and conditions. These statements
reflect the Company's current beliefs, and a number of important factors could
cause actual results to differ materially from those expressed in this press
release.Please see the Company's Annual Report on Form 10-K for the fiscal
year ended December 31, 2012, as well as subsequent filings, filed with the
Securities and Exchange Commission for a more detailed discussion of the risks
and uncertainties associated with the Company's business, including, but not
limited to, the risks and uncertainties associated with venture capital
investing and other significant factors that could affect the Company's actual
results. Except as otherwise required by Federal securities laws, the Company
undertakes no obligation to update or revise these forward-looking statements
to reflect new events or uncertainties.The references to the websites
www.HHVC.com, www.facebook.com and www.nytimes.com have been provided as a
convenience, and the information contained on such websites is not
incorporated by reference into this press release.Harris & Harris Group is
not responsible for the contents of third party websites.

         TEL. NO. (212) 582-0900
Press spacebar to pause and continue. Press esc to stop.